MedPath

AG-LEVETIRACETAM

AG-LEVETIRACETAM

Approved
DIN Number

02485192

Drug Class

Human

Market Date

Mar 2, 2022

Company
HC

angita pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02485192
AIG Number0148843001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX14 LEVETIRACETAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

LEVETIRACETAMActive
Strength: 250 MG
Monograph: LEVETIRACETAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.